von Haehling, S., Ebner, N., and Anker, S. D. (2016) Moving upwards -- the journal of cachexia, sarcopenia and muscle in 2016. Journal of Cachexia, Sarcopenia and Muscle, 7: 391--395. doi: [10.1002/jcsm.12142](10.1002/jcsm.12142).

The good news first, the *Journal of Cachexia*, *Sarcopenia and Muscle* (JCSM) has not only maintained its impact factor, but it has even increased it again, now reaching 7.883 as has been published by Thomson Scientific a few weeks ago. This places JCSM again as the number 9 ranked journal amongst all journals in 'Medicine, General and Internal' (*Table* [1](#jcsm12142-tbl-0001){ref-type="table-wrap"}) and as number 2 ranking publication amongst all nutrition journals, amongst which; however, JCSM is still not offficially listed by Thomson Scientific (*Table* [2](#jcsm12142-tbl-0002){ref-type="table-wrap"}). This new impact factor re‐confirms the inaugural impact factors of 7.413 for 2013 and 7.315 for 2014. As before, we would like to sincerely thank all authors, reviewers and editorial board members for their great efforts to produce JCSM at good quality, and we greatly appreciate and value also the interest and support of all those who enjoy reading JCSM and cite the papers published there.

###### 

Top ten journals in the field 'Medicine: General & Internal', adapted from reference 1

       Journal name                                         Impact factor 2016   Items published in 2014 & 2015
  ---- ---------------------------------------------------- -------------------- --------------------------------
  1    New England journal of medicine                      59.558               701
  2    Lancet                                               44.002               547
  3    Journal of the American medical association (JAMA)   37.684               449
  4    British medical journal                              19.697               519
  5    Annals of internal medicine                          16.440               325
  6    JAMA internal medicine                               14.000               332
  7    PLOS medicine                                        13.585               246
  8    BMC medicine                                         8.005                379
  9    Jounal of cachexia sarcopenia and muscle             7.883                60
  10   Journal of internal medicine                         7.803                198

###### 

Top ten journals in the field 'Nutrition & Dietetics', where the journal of cachexia, sarcopenia and muscle is officially not listed

  ---------------------------------------------------------------------------------------------
       Journal name                                     Impact factor 2016   Items published\
                                                                             in 2014 & 2015
  ---- ------------------------------------------------ -------------------- ------------------
  1    Progress in lipid research                       11.238               63

  2    Annuals review of nutrition                      6.784                37

  3    American journal of clinical nutrition           6.703                671

  4    Nutrition reviews                                5.591                149

  5    Critical reviews in food science and nutrition   5.492                185

  6    International journal of obesity                 5.337                484

  7    Proceedings of the nutrition society             4.703                111

  8    Journal of nutritional biochemistry              4.668                398

  9    Advances in nutrition                            4.576                158

  10   Clinical nutrition                               4.487                318
  ---------------------------------------------------------------------------------------------

This year is special for JCSM for several reasons. One is the publication of an additional (5th) issue in May this year, the other the launch dedicated daughter journals. Indeed, JCSM appears to have sparked more scientific interest in the field of body wasting, cachexia and sarcopenia; and thus, the number of submissions to the main journal remains on the increase. With a 78% rejection rate -- knowing that we have to decline publication of many good papers, simply for lack of space -- we hope to be able to give some of these a home in our new daughter journals -- *JCSM Rapid Communications* and *JCSM Clinical Reports*. These journals will be published online only on an open access basis, and we hope that they will help to create a family of journals dedicated to this fascinating field of research into cachexia, sarcopenia and muscle, and that they will help in clinical decision making and in serving as a source of clinical information and case reports as well.

The main journal, JCSM, at the time of this writing this editorial on 18 July 2016, the journal has received 158 submissions in 2016 alone (*Figure* [1](#jcsm12142-fig-0001){ref-type="fig"}). Last year at this time, we had received 106 submissions .[51](#jcsm12142-bib-0051){ref-type="ref"} Given these higher numbers of submissions, in 2017, we will move to six issues per year to allow publication of more accepted papers. If all goes well, in 2018, we could then possibly move to publication of eight issues per year.

![Number of manuscript submissions to the Journal of Cachexia, Sarcopenia and Muscle by year of publication. \*Numbers for 2016 are estimated on the number of submissions until 18 July 2016 (Reprinted from [51](#jcsm12142-bib-0051){ref-type="ref"}).](JCSM-7-391-g001){#jcsm12142-fig-0001}

We are working hard to provide a timely peer review, which is not always easy, as it is difficult at times to find appropriate reviewers. Articles that are available for the longest time are -- not surprisingly -- those that have been cited most (*Table* [3](#jcsm12142-tbl-0003){ref-type="table-wrap"}). Our 'facts and numbers' editorials remain popular (*Tables* [4](#jcsm12142-tbl-0004){ref-type="table-wrap"} and [5](#jcsm12142-tbl-0005){ref-type="table-wrap"}), and we invite our readers to submit their work or to suggest topics for 'facts and numbers' editorials that are relevant to our readers.

###### 

Top twenty of best cited articles since first publication of the journal of cachexia, sarcopenia and muscle

         First author   Title                                                                                                                                                                                                                               Type               Year   Times cited   Reference
  ------ -------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------ ------------- -----------
  1\.    von Haehling   Cachexia as a major underestimated and unmet medical need: facts and numbers                                                                                                                                                        Editorial          2010   181           ^2^
  2\.    von Haehling   An overview of sarcopenia: facts and numbers on prevalence and clinical impact                                                                                                                                                      Editorial          2010   94            ^3^
  3\.    Dalton         The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial           Original Article   2011   88            ^4^
  4\.    Lenk           Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training                                                                                                                       Review             2010   86            ^5^
  5\.    Mak            Wasting in chronic kidney disease                                                                                                                                                                                                   Review             2011   66            ^6^
  6\.    Fanzani        Molecular and cellular mechanisms of skeletal muscle atrophy: an update                                                                                                                                                             Review             2012   63            ^7^
  7\.    Elkina         The role of myostatin in muscle wasting: an overview.                                                                                                                                                                               Review             2011   63            ^8^
  8\.    Cesari         Biomarkers of sarcopenia in clinical trials‐recommendations from the International Working Group on Sarcopenia                                                                                                                      Original Article   2012   60            ^9^
  9\.    Lainscak       Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease                                                                                                             Original Article   2011   55            ^10^
  10\.   Morley         From sarcopenia to frailty: a road less traveled                                                                                                                                                                                    Editorial          2014   54            ^11^
  11\.   von Haehling   From muscle wasting to sarcopenia and myopenia: update 2012                                                                                                                                                                         Editorial          2012   52            ^12^
  12\.   Lainscak       The obesity paradox in chronic disease: facts and numbers                                                                                                                                                                           Editorial          2012   44            ^13^
  13\.   Patel          Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross‐sectional study and review of literature                                                                                                  Review             2013   43            ^14^
  14\.   Fearon         Myopenia‐a new universal term for muscle wasting                                                                                                                                                                                    Editorial          2011   43            ^15^
  15\.   Sakuma         Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass                                                                                                                                             Review             2012   42            ^16^
  16\.   Schefold       Intensive care unit‐acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock                                                                                                     Review             2010   41            ^17^
  17\.   Busquets       Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance                                                                          Original Article   2012   39            ^18^
  18\.   Wakabayashi    Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management                                                                                                         Review             2014   37            ^19^
  19\.   Farkas         Cachexia as a major public health problem: frequent, costly, and deadly                                                                                                                                                             Review             2013   37            ^20^
  20\.   Rozentryt      The effects of a high‐caloric protein‐rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double‐blind pilot study   Original Article   2010   35            ^21^

###### 

Top twenty of best cited articles published 2014 in the journal of cachexia, sarcopenia and muscle

         First author   Title                                                                                                                                                                 Type               Year   Times cited   Reference
  ------ -------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------ ------------- -----------
  1\.    Morley         From sarcopenia to frailty: a road less traveled                                                                                                                      Editorial          2014   54            ^11^
  2\.    Wakabayashi    Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management                                           Review             2014   37            ^19^
  3\.    von Haehling   Prevalence, incidence and clinical impact of cachexia: facts and numbers‐update 2014                                                                                  Editorial          2014   29            ^22^
  4\.    Morley         Are we closer to having drugs to treat muscle wasting disease?                                                                                                        Editorial          2014   26            ^23^
  5\.    Anker          Muscle wasting disease: a proposal for a new disease classification                                                                                                   Editorial          2014   24            ^24^
  6\.    Ebner          Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies                                               Meeting Report     2014   23            ^25^
  7\.    Heymsfield     Assessing skeletal muscle mass: historical overview and state of the art                                                                                              Review             2014   21            ^26^
  8\.    Pietra         Anamorelin HCI (ONO‐7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia‐cachexia syndrome: preclinical profile                              Original Article   2014   20            ^27^
  9\.    Morley         Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology‐update 2014                                                                Editorial          2014   17            ^28^
  10\.   Fragala        Biomarkers of muscle quality: N‐terminal propeptide of type III procollagen and C‐terminal agrin fragment responses to resistance exercise training in older adults   Original Article   2014   15            ^29^
  11\.   Toledo         Formoterol in the treatment of experimental cancer cachexia: effects on heart function                                                                                Original Article   2014   13            ^30^
  12\.   Rhee           Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?                                                                        Editorial          2014   12            ^31^
  13\.   Argiles        Cachexia: a problem of energetic inefficiency                                                                                                                         Review             2014   11            ^32^
  14\.   Poetsch        The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats                                                  Original Article   2014   11            ^33^
  15\.   Henwood        Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility                                                                Original Article   2014   10            ^34^
  16\.   Ormsbee        Osteosarcopenic obesity: the role of bone, muscle, and fat on health                                                                                                  Review             2014   10            ^35^
  17\.   Alchin         Sarcopenia: describing rather than defining a condition                                                                                                               Review             2014   9             ^36^
  18\.   Mirza          Attenuation of muscle wasting in murine C2C12 myotubes by epigallocatechin‐3‐gallate                                                                                  Original Article   2014   9             ^37^
  19\.   Kirkman        Anabolic exercise in haemodialysis patients: a randomised controlled pilot study                                                                                      Original Article   2014   8             ^38^
  20\.   Palus          Muscle wasting: an overview of recent developments in basic research                                                                                                  Review             2014   8             ^39^

###### 

Top ten of the best cited articles published 2015 in the journal of cachexia, sarcopenia and muscle

         First author   Title                                                                                                                                                                                                                                            Type               Year   Times cited   Reference
  ------ -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------ ------ ------------- -----------
  1\.    Chen           Ghrelin prevents tumour‐ and cisplatin‐induced muscle wasting: characterization of multiple mechanisms involved                                                                                                                                  Original Article   2015   7             ^40^
  2\.    Sasso          A framework for prescription in exercise‐oncology research                                                                                                                                                                                       Editorial          2015   6             ^41^
  3\.    Stephens       Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients                                                                                                                            Original Article   2015   6             ^42^
  4\.    Calvani        Biomarkers for physical frailty and sarcopenia: state of the science and future developments                                                                                                                                                     Review             2015   4             ^43^
  5\.    Ezeoke         Pathophysiology of anorexia in the cancer cachexia syndrom                                                                                                                                                                                       Review             2015   4             ^44^
  6\.    Fearon         Request for regulatory guidance for cancer cachexia intervention trials                                                                                                                                                                          Editorial          2015   4             ^45^
  7      Morley         Rapid screening for sarcopenia                                                                                                                                                                                                                   Editorial          2015   3             ^46^
  8\.    Browen         Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training                                                                                                                                    Review             2015   4             ^47^
  9\.    Faber          Improved body weight and performance status and reduced serum PGE(2) levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro‐esophageal junction   Original Article   2015   4             ^48^
  10\.   Trobec         Influence of cancer cachexia on drug liver metabolism and renal elimination in rats                                                                                                                                                              Original Article   2015   4             ^49^

Finally, we would like to draw your attention to the up‐coming Cachexia Conference, to be held on December 10--11, 2016 in Berlin, Germany. The conference now goes annually, and it has been a source of stimulating ideas and exchange between clinicians and researchers in the field of cachexia and wasting. More information can be found at the following link: [http://society‐scwd.org](http://society-scwd.org).
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